ALS Treatment Options 2026 — Emerging & Approved
Complete ALS treatment landscape: tofersen, gene therapy, stem cells, and 10+ emerging approaches. AI-analyzed research with safety scores and citations.
Standard of Care
Riluzole, Edaravone (Radicava), Relyvrio — primarily symptom management with modest survival extension.
Prevalence
~31,000 cases in the US at any time. ~5,000 new diagnoses per year.
Research by Therapy Category
- Stem Cell Therapy Research
- Anktiva Immunotherapy Research
- Bioactive Peptide Research
- Gene Therapy & CRISPR Research
- Nutraceutical & Vitamin Research
- Antiparasitic Drug Repurposing Research
- Lifestyle Intervention Research
- Engineered Cell Therapy Research
- Off-Label Drug Repurposing Research
- Microbiome & Mitochondrial Intervention Research
- Diagnostic Test & Biomarker Research
- Computational Chemistry & Molecular Analysis
- Hormonal & Women's Health Research
- Disease Mechanism Education for Patients